The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction

Addiction Biology
José Antonio López-MorenoMiguel Navarro

Abstract

Addiction is a chronic, recurring and complex disorder. It is characterized by anomalous behaviors that are linked to permanent or long-lasting neurobiological alterations. Furthermore, the endocannabinoid system has a crucial role in mediating neurotransmitter release as one of the main neuromodulators of the mammalian central nervous system. The purpose of the present review is to instruct readers about the functional and structural interactions between the endocannabinoid system and the main neurotransmitter systems of the central nervous system in the context of drug addiction. With this aim, we have systematically reviewed the main findings of most of the existing literature that explores cross-talk in the five brain areas that are most traditionally implicated in addiction: amygdala, prefrontal cortex, nucleus accumbens, hippocampus and ventral tegmental area (VTA). The neurotransmission systems influenced by the pharmacology of the endocannabinoid system in these brain areas, which are reviewed here, are gamma-aminobutyric acid (GABA), glutamate, the main biogenic amines (dopamine, noradrenaline and serotonin), acetylcholine and opioids. We show that all of these neurotransmitter systems can be modulated differentially i...Continue Reading

References

Jun 1, 1997·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·J D JentschR H Roth
May 26, 1997·European Journal of Pharmacology·G L GessaG Carta
Dec 24, 1997·Naunyn-Schmiedeberg's Archives of Pharmacology·E SchlickerM Göthert
Oct 17, 1998·Progress in Neurobiology·F Fadda, Z L Rossetti
Aug 26, 1999·Life Sciences·R E Hampson, S A Deadwyler
Feb 23, 2000·Neuroscience·R Rodríguez-PuertasA Pazos
Jul 6, 2000·Journal of Physiology and Biochemistry·R Hernández-TristánM L Leret
Dec 7, 2000·Chemistry and Physics of Lipids·R Mechoulam, L Hanus
Feb 13, 2001·European Journal of Pharmacology·O J Manzoni, J Bockaert
Feb 24, 2001·Naunyn-Schmiedeberg's Archives of Pharmacology·M KathmannE Schlicker
Aug 8, 2001·The European Journal of Neuroscience·M PistisG L Gessa
May 31, 2002·Pharmacological Reviews·A C HowlettR G Pertwee
Jun 13, 2002·Proceedings of the National Academy of Sciences of the United States of America·David RobbeOlivier J Manzoni
Jun 25, 2002·European Journal of Pharmacology·Nobuaki EgashiraMichihiro Fujiwara
Jun 25, 2002·Nature Neuroscience·Gregory CarlsonBradley E Alger
Jul 9, 2002·The European Journal of Neuroscience·Bela SzaboIlka Wallmichrath

❮ Previous
Next ❯

Citations

Jul 21, 2011·European Archives of Psychiatry and Clinical Neuroscience·Lorenzo SomainiGilberto Gerra
Oct 21, 2011·Nature Reviews. Neuroscience·Rita Z Goldstein, Nora D Volkow
Nov 11, 2011·International Journal of Environmental Research and Public Health·Geoffrey L ReamEloise Dunlap
Nov 11, 2011·International Journal of Environmental Research and Public Health·Geoffrey L ReamEloise Dunlap
Jan 1, 2011·Schizophrenia Research and Treatment·Fabio PanarielloAndrea de Bartolomeis
Jan 30, 2014·Annual Review of Clinical Psychology·Ruud van Winkel, Rebecca Kuepper
Nov 16, 2013·Psychiatry Journal·Geoffrey L ReamEloise Dunlap
Jan 29, 2014·Progress in Neuro-psychopharmacology & Biological Psychiatry·Shiva HashemizadehAmeneh Rezayof
Aug 26, 2010·Pharmaceuticals·Marco BortolatoSimone Tambaro
Oct 29, 2015·Developmental Cognitive Neuroscience·Francesca M FilbeyVirendra Mishra
Mar 17, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·Linda Console-BramMary E Abood
Jan 24, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·Megan L FitzgeraldVirginia M Pickel
Jun 15, 2011·Neuropharmacology·Nimish Sidhpura, Loren H Parsons
Feb 22, 2011·Neuroscience·R MaldonadoP Robledo
Jul 18, 2009·Neuropharmacology·Pauline LafenêtreGiovanni Marsicano
Oct 1, 2008·Drug Discovery Today·Rosemarie Panetta, Michael T Greenwood
Sep 16, 2015·Psychological Medicine·E Appiah-KusiS Bhattacharyya
Apr 2, 2009·Addiction·Arpana Agrawal, Michael T Lynskey
Jul 2, 2010·British Journal of Pharmacology·Matthew W Buczynski, Loren H Parsons
May 1, 2013·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Samantha J BroydNadia Solowij
Jun 10, 2015·Journal of Receptor and Signal Transduction Research·Colin G Rousseaux, Stephanie F Greene
Jul 19, 2015·Behavioural Brain Research·Francesca M FilbeyAriel Ketcherside
Apr 21, 2016·Neuroscience and Biobehavioral Reviews·Liana Fattore, Marco Diana
Feb 17, 2015·Pharmacology, Biochemistry, and Behavior·Somayeh BarzegarIraj Salehi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Basal Forebrain- Circuits

Basal forebrain is a region in the brain important for production of acetylcholine and is the major cholinergic output of the CNS. Discover the latest research on circuits in the basal forebrain here.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Related Papers

Science
Rachel I Wilson, Roger A Nicoll
The Journal of Comparative Neurology
L A MatsudaS J Lolait
Trends in Neurosciences
Rafael MaldonadoFernando Berrendero
© 2022 Meta ULC. All rights reserved